Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response 2024-05-24 22:07
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual Meeting 2024-05-24 22:00
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024 2024-05-24 20:00
YS Biopharma Announces Name Change to LakeShore Biopharma 2024-05-24 19:30
61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals 2024-05-24 19:00
K-Pet develops disease prevention solutions to extend the healthy life of pets 2024-05-24 18:13
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting 2024-05-24 17:36
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor 2024-05-24 16:33
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-05-24 16:32
Compassionate closure for those who are unable to fulfil hopes and expectations of fertility treatment 2024-05-24 16:00
United in Our Fight Against Cancer - New Frontier Group Acquires Hong Kong Integrated Oncology Centre 2024-05-24 13:59
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology Company 2024-05-24 13:00
CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website 2024-05-24 13:00
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates 2024-05-24 09:15
Busting fear barrier about hormone replacement therapy in new era of menopause management 2024-05-24 09:00
Antengene To Present One Oral and Four Abstracts at ASCO 2024 2024-05-24 08:30
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 2024-05-24 08:00
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 2024-05-24 08:00
ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE 2024-05-24 06:41
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024 2024-05-23 23:00
1 84 85 86 87 88 1597